Sector revisions Charles River Laboratories International, Inc. CBOE

Stocks

Market Closed - CBOE 23:59:50 12/10/2026 +04			5-day change	1st Jan Change
302.27 ^USD	+0.10%		+3.99%	+51.24%

10-12	Morgan Stanley Adjusts Price Target on Charles River Laboratories International to $340 From $300	MT
10-06	Charles River Laboratories International, Inc. and Autolomous Launch Apollo Orchestrate Within Charles River's Apollo Platform	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1y. EPS revision	Nbr of analysts
WUXI APPTEC CO., LTD.		17
ARGENX SE		15
LONZA GROUP AG		23
IQVIA HOLDINGS INC.		19
REVOLUTION MEDICINES, INC.		23
BEONE MEDICINES AG		27
CELLTRION, INC.		22
WUXI BIOLOGICS (CAYMAN) INC.		23
BIONTECH SE		20
INSMED INCORPORATED		23
GENMAB A/S		15
MEDPACE HOLDINGS, INC.		13
PHARMAESSENTIA CORPORATION		8
ASCENDIS PHARMA A/S	-	20
EUROFINS SCIENTIFIC SE		14
EXELIXIS, INC.		15
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.		15
SUMMIT THERAPEUTICS INC.		13
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.		19
Average		18
Weighted average by Cap.		19